Does AD26.COV2.S Cause Thrombocytopenia? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Thrombocytopenia have been filed in association with AD26.COV2.S. This represents 1.2% of all adverse event reports for AD26.COV2.S.
5
Reports of Thrombocytopenia with AD26.COV2.S
1.2%
of all AD26.COV2.S reports
1
Deaths
4
Hospitalizations
How Dangerous Is Thrombocytopenia From AD26.COV2.S?
Of the 5 reports, 1 (20.0%) resulted in death, 4 (80.0%) required hospitalization.
Is Thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AD26.COV2.S. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does AD26.COV2.S Cause?
Covid-19 (58)
Fatigue (47)
Off label use (43)
Headache (42)
Pain (41)
Pyrexia (40)
Malaise (38)
Arthralgia (32)
Chills (31)
Nausea (25)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which AD26.COV2.S Alternatives Have Lower Thrombocytopenia Risk?
AD26.COV2.S vs ADAGRASIB
AD26.COV2.S vs ADALIMUMAB
AD26.COV2.S vs ADALIMUMAB-AACF
AD26.COV2.S vs ADALIMUMAB-AATY
AD26.COV2.S vs ADALIMUMAB-ADAZ